# A Probiotic for Health Outcomes in Short-Term Overseas Travel

> **NCT07705659** · NA · NOT_YET_RECRUITING · sponsor: **DiproBio (Shanghai) Co., Ltd.** · enrollment: 40 (estimated)

## Conditions studied

- Changes in Gut Microbiota, Gut Metabolites, Respiratory Symptoms, and Well-being Index

## Interventions

- **DIETARY_SUPPLEMENT:** Bifidobacterium longum
- **DIETARY_SUPPLEMENT:** Maltodextrin

## Key facts

- **NCT ID:** NCT07705659
- **Lead sponsor:** DiproBio (Shanghai) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-30
- **Primary completion:** 2027-02-28
- **Final completion:** 2027-03-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07705659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07705659, "A Probiotic for Health Outcomes in Short-Term Overseas Travel". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07705659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*